Hyrio Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.70 M
as on 08-12-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.72 M
as on 08-12-2024
- Revenue -97.95%
(FY 2020)
- Profit -62.39%
(FY 2020)
- Ebitda -448.09%
(FY 2020)
- Net Worth -7.63%
(FY 2020)
- Total Assets 3.86%
(FY 2020)
About Hyrio Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹5.72 M.
Neeta Mishra and Divya Bajaj serve as directors at the Company.
- CIN/LLPIN
U51397MH2008PTC185185
- Company No.
185185
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hyrio Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Bajaj  | Managing Director | 29-Jul-2008 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeta Mishra | Director | 04-Oct-2008 | Current |
Financial Performance of Hyrio Laboratories.
Hyrio Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 97.95% decrease. The company also saw a substantial fall in profitability, with a 62.39% decrease in profit. The company's net worth dipped by a decrease of 7.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyrio Laboratories?
In 2020, Hyrio Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Om Business Support Services Private LimitedActive 10 years 4 monthsNeeta Mishra is a mutual person
- Doctors Risk Medico-Legal Services Private LimitedActive 18 years 10 months
Neeta Mishra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 May 2013 | ₹0.72 M | Open |
The Bharat Co-Operative Bank (Mumbai) Limited Creation Date: 10 May 2012 | ₹1.50 M | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 10 May 2012 | ₹3.50 M | Open |
How Many Employees Work at Hyrio Laboratories?
Unlock and access historical data on people associated with Hyrio Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyrio Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyrio Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
